CraniUS Therapeutics
PrivateLast Round
Series B
Jan 28, 2026
Total Funding Raised
$40.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CraniUS Therapeutics operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Series B round in January 2026.
CraniUS Therapeutics is a neurotechnology company developing a fully implantable platform to bypass the blood-brain barrier for long-term, programmable drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CraniUS Therapeutics Comparables
Compare CraniUS Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theracle | 85% | |
| Cognos Therapeutics Inc | 84% | |
| Precision NeuroMed | 82% |
For institutional investors. Book with your work email.
CraniUS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 28, 2026 | ||||
| Grant | Jun 26, 2024 | ||||
| Series A | Sep 27, 2022 |
For institutional investors. Book with your work email.
CraniUS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maryland Department of Commerce | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 98% MoM, reaching 1.6K.
- Jan 28, 2026
$20M round completed.
For institutional investors. Book with your work email.
CraniUS Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CraniUS Therapeutics's valuation, stock price, and market status.
Is CraniUS Therapeutics a public or private company?
CraniUS Therapeutics is a private company.
What is the current stock price of CraniUS Therapeutics?
CraniUS Therapeutics is a private company, so its shares have no public market price. Caplight tracks CraniUS Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CraniUS Therapeutics worth (valuation)?
Valuation information for CraniUS Therapeutics is not publicly available.
Can I buy CraniUS Therapeutics stock?
CraniUS Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CraniUS Therapeutics's last funding round?
CraniUS Therapeutics's most recent funding round was Series B on January 28, 2026.
Who are the main investors in CraniUS Therapeutics?
Key investors in CraniUS Therapeutics include Maryland Department of Commerce.
Will CraniUS Therapeutics IPO soon?
No public IPO plans have been announced for CraniUS Therapeutics.
How can I track CraniUS Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in CraniUS Therapeutics's shares on secondary markets.